Hepatitis C/HIV Coinfection

Prolonged HAART may cause higher hepatitis C load in HIV coinfected

Published in Hepatitis Weekly, February 10th, 2003

by Sonia Nichols, senior medical writer - Long-term use of highly active antiretroviral therapy (HAART) may be responsible for raising hepatitis C virus (HCV) loads in patients coinfected with human immunodeficiency virus (HIV).

Researchers at Stanford University School of Medicine in California have detected higher HCV viral loads and greater quasispecies diversity in such individuals, according to a report in the February 2003 edition of Journal of Virology.

"Three cohorts of coinfected patients were analyzed retrospectively over a period of 7 to 10 months: group A was antiretroviral drug naive at baseline and then on HAART for the remainder...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2003-02-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry